Article
Statin treatment, phenotypic frailty and mortality among community-dwelling octogenarian men: the HBS cohort.
Age and ageing - 27 Feb 2020
Luotola Kari, Jyväkorpi Satu, Urtamo Annele, Pitkälä Kaisu H, Kivimäki Mika, Strandberg Timo E
Abstract excerpt
BACKGROUND: statin treatment has increased also among people aged 80 years and over, but adverse effects potentially promoting frailty and loss of resilience are frequent concerns. METHODS: in the Helsinki Businessmen Study, men born in 1919-34 (original n = 3,490) have been followed up since the 1960s. In 2011, a random subcohort of home-living survivors (n = 525) was assessed using questionnaires and clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
